Diabetes-induced Oxidative DNA Damage Alters P53-p21CIP1/Waf1 Signaling in the Rat Testis
Overview
Authors
Affiliations
Diabetes is increasingly becoming a major cause of large-scale morbidity and mortality. Diabetes-induced oxidative stress alters numerous intracellular signaling pathways. Although testicular dysfunction is a major concern in diabetic men, the mechanistic alterations in the testes that lead to hypogonadism are not yet clear. Oxidative mitochondrial DNA damage, as indicated by 7,8-dihydro-8-oxo-2'-deoxyguanosine, and phosphorylation of p53 at ser315 residue (p-p53ser315) increased in a stage- and cell-specific manner in the testes of rats that were diabetic for 1 month (DM1). Prolongation of diabetes for 3 months (DM3) led to an increase in nuclear oxidative DNA damage in conjunction with a decrease in the expression of p-p53ser315. The nuclei of pachytene and preleptotene spermatocytes, steps 1, 11, and 12 spermatids, secondary spermatocytes and the Sertoli cells, and the meiotic figures showed an increase in the expression of p-p53ser315. An increase in the expression of a downstream target of p53 and protein 21(cyclin-dependent kinase interacting protein 1/wild-type p53-activated factor 1) (p21(CIP1/Waf1)) in both diabetic groups did not show any time-dependent effects but occurred concurrent with an upregulation of p-p53ser315 in DM1 and a downregulation of the protein in DM3. In diabetic groups, the expression of p21(CIP1/Waf1) was mainly cytoplasmic but also perinuclear in pachytene spermatocytes and round spermatids. The cytoplasmic localization of p21(CIP1/Waf1) may be suggestive of an antiapoptotic role for the protein. The perinuclear localization is probably related to the cell cycle arrest meant for DNA damage repair. Diabetes upregulates p21(CIP1/Waf1) signaling in testicular germ cells in association with alteration in p-p53ser315 expression, probably to counteract DNA damage-induced cell death.
Hu Y, Cai T, Yan R, Liu B, Ding B, Ma J Int J Endocrinol. 2024; 2024:8797972.
PMID: 38817616 PMC: 11139535. DOI: 10.1155/2024/8797972.
Elbanna A, Osman A, Hossny A, ElBanna H, Abo El-Ela F Int J Immunopathol Pharmacol. 2023; 37:3946320231172745.
PMID: 37099672 PMC: 10141268. DOI: 10.1177/03946320231172745.
Salah M, Ismail K, Khadrawy S Mol Biol Rep. 2021; 49(1):189-203.
PMID: 34709572 DOI: 10.1007/s11033-021-06858-0.
Jiang S, Dong H, Fang K, Chen G, Li J, Xu L Chin J Integr Med. 2021; 27(6):432-439.
PMID: 33459971 DOI: 10.1007/s11655-021-2863-2.
Ji Z, Zhou Y, Wang H, Li S, Liang G, Mao J Biomed Res Int. 2020; 2020:1283214.
PMID: 32076604 PMC: 7013357. DOI: 10.1155/2020/1283214.